Bolt Biotherapeutics effects 1-for-20 reverse stock split

Bolt Biotherapeutics, Inc.

Reverse stock split at 1-for-20 ratio effective June 6, 2025.
Common stock begins trading on split-adjusted basis June 9, 2025 on Nasdaq under ticker BOLT.
New CUSIP number is 097702203; par value unchanged at $0.00001 per share.
No fractional shares issued; cash payment in lieu of fractional shares.
Proportionate adjustments to outstanding stock options, equity plans, and warrants.

item 5.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.